Pay in 4 interest-free payments of $6.51 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
BPS Bioscience offers products to assess the efficacy of candidate drugs targeting GLP-1
As of August 2026, we now have the longest retatrutide data from TRIUMPH-1's 104-week extension (BMI 35 subgroup)
The complex role of adiponectin in chronic kidney disease
Need assistance
Rated 5 out of 5 Jose Morais Rated 5 out of 5 Anonymous Rated 5 out of 5 Raquel Matos Rated 5 out of 5 RICHARD LEWIS Rated 5 out of 5 love this product Carl Esquivel Rated 5 out of 5 SARAH SHUMAN Rated 5 out of 5 rebecca gilfoil Rated 5 out of 5 5-star Anonymous Rated 5 out of 5 Anonymous Rated 5 out of 5 Elorah Gray Rated 5 out of 5 Anonymous Rated 5 out of 5 Anonymous Rated 5 out of 5 Angela S
:max_bytes(150000):strip_icc()/VWH-GettyImages-1807239973-13b3185e5c224ffa8eafa762fae1ef8d.jpg)
Similar frameworks could influence treatment selection for metabolic disease, cardiovascular risk reduction, NASH/MASH, and other conditions where GLP-1-based therapies are being actively studied
![Volcanion (025/072) [Sword & Shield: Shining Fates]](https://daviscardsandgames.com/cdn/shop/products/2cf56c83-2275-5a92-92ec-759b7f1d309e_800x.jpg?v=1696289526)
)
